- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Jay Berfas
Jay Berfas, Publisher
T: (212) 951-6614
jberfas@advanstar.com
Jay Berfas joined Advanstar Communications in September 2006 as Group Publisher of Pharmaceutical Executive and Pharmaceutical Representative Magazines. In this role, Jay is responsible for the overall business and strategic development of print and electronic media products for the Group. Jay brings to Advanstar over 30 years of publishing and senior management experience. Previously, Jay held posts as Vice President for Institutional Investor magazine, where he spent 14 years in management positions and Global Finance, where he headed worldwide advertising sales as Associate Publisher from 1992-2000. Until October 2005, Jay was Group Publisher of SourceMedia's Banking Magazines Group, where he managed the Group's editorial and business operations, launched several successful e-newsletters, and helped create a successful Webcast business. Jay has a MA from New York University and earned a Bachelor of Arts with honors from Queens College of the City University of New York.
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.
